The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

Nanomedicine has emerged as a novel cancer treatment and diagnostic modality, whose design constantly evolves towards increasing the safety and efficacy of the chemotherapeutic and diagnostic protocols. Molecular diagnostics, which create a great amount of data related to the unique molecular signat...

Full description

Bibliographic Details
Main Authors: Nikola Geskovski, Nadica Matevska-Geshkovska, Simona Dimchevska Sazdovska, Marija Glavas Dodov, Kristina Mladenovska, Katerina Goracinova
Format: Article
Language:English
Published: Beilstein-Institut 2021-04-01
Series:Beilstein Journal of Nanotechnology
Subjects:
Online Access:https://doi.org/10.3762/bjnano.12.31